<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001241359</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000925741</issuerCik>
      <issuerName>BioCardia, Inc.</issuerName>
      <secFileNumber>001-38999</secFileNumber>
      <issuerAddress>
        <com:street1>320 SOQUEL WAY</com:street1>
        <com:city>SUNNYVALE</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94085</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>650-226-0120</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>GILLIS EDWARD M</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Charles Schwab Corp</name>
        <address>
          <com:street1>3000 Schwab Way</com:street1>
          <com:city>Westlake</com:city>
          <com:stateOrCountry>TX</com:stateOrCountry>
          <com:zipCode>76262</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>3257</noOfUnitsSold>
      <aggregateMarketValue>6611.00</aggregateMarketValue>
      <noOfUnitsOutstanding>4584285</noOfUnitsOutstanding>
      <approxSaleDate>12/17/2024</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>06/01/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Units</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>3257</amountOfSecuritiesAcquired>
      <paymentDate>06/01/2023</paymentDate>
      <natureOfPayment>Equity Compensation</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>12/17/2024</noticeDate>
      <signature>Edward M. Gillis</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2698}]
144
0001241359
XXXXXXXX
LIVE
0000925741
BioCardia, Inc.
001-38999
320 SOQUEL WAY
SUNNYVALE
CA
94085
650-226-0120
GILLIS EDWARD M
Officer
Common
Charles Schwab Corp
3000 Schwab Way
Westlake
TX
76262
3257
6611.00
4584285
12/17/2024
Nasdaq
Common
06/01/2023
Restricted Stock Units
Issuer
N
3257
06/01/2023
Equity Compensation
Y
12/17/2024
Edward M. Gillis